Skip to search formSkip to main contentSkip to account menu

gefitinib Oral Tablet [Iressa]

National Institutes of Health

Related topics

Related topics

3 relations
IressaOral Tablet

Narrower (1)

gefitinib 250 MG Oral Tablet [Iressa]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Six cases of purpuric eruptions induced by epidermal growth factor receptor inhibitors
Erlotinib (Tarceva®) and gefitinib (Iressa®) are novel oral tyrosine kinase inhibitors targeting epidermal growth factor receptor… 
2012
2012
Abstract A8: Combating adaptive ERBB3-mediated resistance to ERBB2 inhibitors: In Silico optimization of MM-111 and lapatinib dosing regimens
Upregulation of ErbB3 (HER3) signaling has been implicated as a resistance mechanism to targeted ErbB1 and ErbB2 (HER1/2… 
2011
2011
Abstract C228: Preclinical analysis of therapeutic antibody efficiancy using an organoid model-based drug testing platform.
A common problem in translational research is the fact that findings from cell line experiments cannot be transferred one to one… 
Review
2008
Review
2008
Molekulardiagnostik von Mutationen des epidermalen Wachstumsfaktor-Rezeptors und Aktivierung nachgeschalteter Signalwege in nichtkleinzelligen Lungenkarzinomen
ZusammenfassungDas Bronchialkarzinom ist trotz kontinuierlicher Verbesserung der diagnostischen und therapeutischen Ansätze die h… 
2005
2005
Molecular medicine and its impact on practice
Molecular medicine has had its greatest impact in the field of urologic oncology. Evolution of cancer cells has endowed them with…